JPRN-UMIN000007184已完成2 期
Phase2 study of limited Surgery for T1 or T2 lower rectal Cancer with adjuvant chemoradiotherapy - Limited Surgery for T1 or T2 lower rectal Cancer with adjuvant chemoradiotherapy
Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group0 个研究点目标入组 50 人开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active synchronous or metachronous malignancy carcinoma in situ. 2) Non-treated radiotherapy 3) Medical history of severe anaphylaxis or allergia to any drug. 4) Severe diarrhea. 5)Undergoing treatment with fluorocytosine. 6) Severe complication. 7) Pregnant or lactating woman at any time during study. Men of the fertility hope. 8) Severe mental disorder. 9) Patients judged inappropriate for the study by their physicians.
研究者
相似试验
招募中
2 期
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000011445Department of Surgery, Osaka University Graduate School of Medicine50
招募中
2 期
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.(HiSCO 06)Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000024004Hiroshima Surgical Study group of Clinical Oncology (HiSCO)30
已完成
2 期
A phase II feasibility study of surgical intervention for single station cN2 (UICC 6) non-small cell lung cancer (JNETS 0801)on-small cell lung cancerJPRN-UMIN000013247Japan North-East Area Thoracic Oncology Study Group34
招募中
2 期
A phase 2 study of the decision of surgical adjustment time based on IDRF (Image Defined Risk Factors), and chemotherapy that gradually improve strength for intermediate risk neuroblastomaintermediate risk neuroblastomasJPRN-UMIN000004700Japan Neuroblastoma Study Group73
进行中（未招募）
2 期
A phase 2 study for intermediate risk neuroblastoma based on IDRF (Image Defined Risk Factors)neuroblastomaJPRN-jRCTs051180203iehara tomoko75